Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shih-Jen Liu

Showing results (31-40 of 115) with videos related to

Pageof 12
Sort By:
Journal of Biomedical Science|April 16, 2020
Recombinant lipidated Zika virus envelope protein domain III elicits durable neutralizing antibody responses against Zika virus in miceMei-Yu Chen, Kit Man Chai, Chen-Yi Chiang, et al.
Molecular Cancer|March 20, 2014
Toll-like receptor 9 agonist enhances anti-tumor immunity and inhibits tumor-associated immunosuppressive cells numbers in a mouse cervical cancer model following recombinant lipoprotein therapyLi-Sheng Chang, Chih-Hsiang Leng, Yi-Chen Yeh, et al.
Cancers|April 2, 2020
Liposomal TLR9 Agonist Combined with TLR2 Agonist-Fused Antigen Can Modulate Tumor Microenvironment through Dendritic CellsKuan-Yin Shen, Hsin-Yu Liu, Wan-Lun Yan, et al.
Journal of Virology|October 17, 2006
Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome coronavirusYi-Ping Shih, Chia-Yen Chen, Shih-Jen Liu, et al.
Diagnostics (Basel, Switzerland)|October 23, 2021
A Novel Rapid Test to Detect Anti-SARS-CoV-2 N Protein IgG Based on Shear Horizontal Surface Acoustic Wave (SH-SAW)Yu-Chi Peng, Chia-Hsuan Cheng, Hiromi Yatsuda, et al.
Clinical and Vaccine Immunology : CVI|July 30, 2010
T-cell response to human papillomavirus type 58 L1, E6, And E7 peptides in women with cleared infection, cervical intraepithelial neoplasia, or invasive cancerPaul K S Chan, Shih-Jen Liu, T H Cheung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 2014
Molecular mechanisms of TLR2-mediated antigen cross-presentation in dendritic cellsKuan-Yin Shen, Ying-Chyi Song, I-Hua Chen, et al.
Cancer Letters|May 1, 2016
Chimeric peptide containing both B and T cells epitope of tumor-associated antigen L6 enhances anti-tumor effects in HLA-A2 transgenic miceSu-I Lin, Ming-Hsi Huang, Yu-Wen Chang, et al.
American Journal of Cancer Research|January 22, 2019
A therapeutic vaccine targeting HPV E6/E7 with intrinsic Toll-like receptor 2 agonist activity induces antitumor immunityYuh-Pyng Sher, Chi Lee, Shin-Yu Liu, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Enzymatic stability and immunoregulatory efficacy of a synthetic indolicidin analogue with regular enantiomeric sequenceChing-Yun Chang, Chih-Wei Lin, Sheng-Kuo Chiang, et al.
Pageof 12

Showing results (31-40 of 115) with videos related to

Sort By:
Pageof 12
Journal of Biomedical Science|April 16, 2020
Recombinant lipidated Zika virus envelope protein domain III elicits durable neutralizing antibody responses against Zika virus in miceMei-Yu Chen, Kit Man Chai, Chen-Yi Chiang, et al.
Molecular Cancer|March 20, 2014
Toll-like receptor 9 agonist enhances anti-tumor immunity and inhibits tumor-associated immunosuppressive cells numbers in a mouse cervical cancer model following recombinant lipoprotein therapyLi-Sheng Chang, Chih-Hsiang Leng, Yi-Chen Yeh, et al.
Cancers|April 2, 2020
Liposomal TLR9 Agonist Combined with TLR2 Agonist-Fused Antigen Can Modulate Tumor Microenvironment through Dendritic CellsKuan-Yin Shen, Hsin-Yu Liu, Wan-Lun Yan, et al.
Journal of Virology|October 17, 2006
Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome coronavirusYi-Ping Shih, Chia-Yen Chen, Shih-Jen Liu, et al.
Diagnostics (Basel, Switzerland)|October 23, 2021
A Novel Rapid Test to Detect Anti-SARS-CoV-2 N Protein IgG Based on Shear Horizontal Surface Acoustic Wave (SH-SAW)Yu-Chi Peng, Chia-Hsuan Cheng, Hiromi Yatsuda, et al.
Clinical and Vaccine Immunology : CVI|July 30, 2010
T-cell response to human papillomavirus type 58 L1, E6, And E7 peptides in women with cleared infection, cervical intraepithelial neoplasia, or invasive cancerPaul K S Chan, Shih-Jen Liu, T H Cheung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 2014
Molecular mechanisms of TLR2-mediated antigen cross-presentation in dendritic cellsKuan-Yin Shen, Ying-Chyi Song, I-Hua Chen, et al.
Cancer Letters|May 1, 2016
Chimeric peptide containing both B and T cells epitope of tumor-associated antigen L6 enhances anti-tumor effects in HLA-A2 transgenic miceSu-I Lin, Ming-Hsi Huang, Yu-Wen Chang, et al.
American Journal of Cancer Research|January 22, 2019
A therapeutic vaccine targeting HPV E6/E7 with intrinsic Toll-like receptor 2 agonist activity induces antitumor immunityYuh-Pyng Sher, Chi Lee, Shin-Yu Liu, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Enzymatic stability and immunoregulatory efficacy of a synthetic indolicidin analogue with regular enantiomeric sequenceChing-Yun Chang, Chih-Wei Lin, Sheng-Kuo Chiang, et al.
Pageof 12